InvestorsHub Logo

miauseradvafazsd

10/10/18 4:47 PM

#8098 RE: miauseradvafazsd #8097

Maybe they’re waiting for a revenue development of their own products and using it to boost their claim that studies back it up?

BuddyLou

10/10/18 5:22 PM

#8100 RE: miauseradvafazsd #8097

No it wasn't. Noreen and the board are deliberately keeping information from the trading platforms and the public. My personnel thought, is we have talked about the Nov 30 2017 shareholder letter being a legal document, and Noreen, IMUN and the legal team have failed to adhere to. So, my personal thought, is this was an attempt to say: "We released information on our website". thinking this would fulfill their legal monthly company update, and to keep the shareholder. I do not know if thag would be seen as an adequate meathod, but what I will say, is that is a great PR, that should have been released as an official news release, but was not.
The question every IMUN investor needs to be asking themselves is why? And asking Noreen and the board. The good thing is it further adds ammunition to the theory that Noreen and the IMUN board is deliberately keeping this stock down by staying silent.
I don't know about everyone else, but that could have given us a little bump in price in the trading volume and stock price. So why would the CEO or IMUN not release this as an official PR on all the trading platforms to be seen by all in the market??????

goforthebet

10/11/18 3:00 AM

#8124 RE: miauseradvafazsd #8097

was this study triggered by Immune Therapeutics or from some neutral source? thanks for posting